Search for the latest oncology news by tumour type
New four-year follow-up results from the Phase 3 GLOW study (Abstract #93), were announced during…
The immunotherapy blinatumomab was found to improve overall survival for patients with no measurable residual…
Research led by Randal J. Kaufman, Ph.D., has found that misfolded proteins in liver cells contribute…
A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive…
Many children with ALL have a good outcome of their disease. After two years of chemotherapy…
A CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) is safe and shows encouraging signs of…
Researchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to…
Palbociclib in combination with an aromatase inhibitor is, among other therapeutic indications, approved for first-line…
New research out of VCU Massey Cancer Center, USA, points to the inactivation of a…
Like the New York City subway system, the DNA in our cells needs to operate…